Activity of matrix metallo proteinases (MMPs) and the tissue inhibitor of MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2767-2774

  Patruno, Antonia ^a   Pesce, Mirko ^a   Marrone, Alessandro ^a   Speranza, Lorenza ^a   Grilli, Alfredo ^a   De Lutiis, Maria Anna ^a   Felaco, Mario ^a   Reale, Marcella ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE; NITROGEN; REACTIVE NITROGEN SPECIES; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTIOXIDANT ACTIVITY; ARTICLE; ELECTROMAGNETIC FIELD; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; MOLECULAR MODEL; NITRATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANTIOXIDANTS; CELL LINE, TUMOR; ELECTROMAGNETIC FIELDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, MOLECULAR; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TYROSINE;

HELIOTHIS ZEA VIRUS 1;

EID: 84857499376     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23024     Document Type: Article

References (48)

1. Aebi HE. 1974. Methods of enzymatic analysis. In: Bergmayer HU, editor. Chemie. 2nd edn, Vol. 2. Weinheim: F.R.G. pp 673-684.
2. Akdag MZ, Bilgin MH, Dasdag S, Tumer C. 2007. Alteration of nitric oxide production in rats exposed to a prolonged, extremely low-frequency magnetic field. Electromagn Biol Med 26:99-106.
3. Baricos WH, Shah SV. 1991. Proteolytic enzymes as mediators of glomerular injury. Kidney Int 40:161-173.
4. Bogdan C. 2001. Nitric oxide and the immune response. Nat Immunol 10:907-916.
5. Brew K, Dinakarpandian D, Nagase H. 2000. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477:267-283.
6. Brocklehurst B, McLauchlan KA. 1996. Free radical mechanism for the effects of environmental electromagnetic fields on biological systems. Int J Radiat Biol 69:3-24.
7. Colasanti M, Suzuki H. 2000. The dual personality of NO. Trends Pharmacol Sci 21:249-252.
8. Eberhardt W, Beckand Pfeilschifter KFJ. 2002. Mechanisms of dexamethasone-mediated inhibition of cAMP-induced tPA expression in rat mesangial cells. Kidney Int 61:20-30.
9. Frahm J, Lantow M, Lupke M, Weiss DG, Simkó M. 2006. Alteration in cellular functions in mouse macrophages after exposure to 50Hz magnetic fields. J Cell Biochem 99:168-177.
10. Frears ER, Zhang Z, Blake DR, O'Connell JP, Winyard PG. 1996. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 381:21-24.
11. Fukuto JM, Ignarro LJ. 1997. In vivo aspects of nitric oxide (NO) chemistry: Does peroxynitrite (OONO) play a major role in cytotoxicity? Acc Chem Res 30:149-152.
12. Groupp ER, Donovan-Peluso M. 1996. Lipopolysaccharide induction of THP-1 cells activates binding of c-Jun, Ets, and Egr-1 to the tissue factor promoter. JBC 271:12423-12430.
13. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA. 2002. S-nitrosylation of matrix metalloproteinases: Signaling pathway to neuronal cell death. Science 297:1186-1190.
14. Hevel JM, Marletta MA. 1994. Nitric-oxide synthase assays. Methods Enzymol 233:250-258.
15. Holvoet S, Vincent C, Schmitt D, Serres M. 2003. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Exp Cell Res 290:108-119.
16. Hsu YC, Wang LF, Chien YW, Lee WR. 2007. Induction of TIMP-1 and HSP47 synthesis in primary keloid fibroblasts by exogenous nitric oxide. J Dermatol Sci 45:37-44.
17. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269.
18. Iyer S, Wei S, Brew K, Acharya KR. 2007. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1. J Biol Chem 282:364-371.
19. Lepidi S, Kenagy RD, Raines EW, Chiu ES, Chait A, Ross R, Clowes AW. 2001. MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen. J Vasc Surg 34:1111-1118.
20. Lupke M, Rollwitz J, Simkó M. 2004. Cell activating capacity of 50Hz magnetic fields to release reactive oxygen intermediates in human umbilical cord blood-derived monocytes and in Mono Mac 6 cells. Free Radic Res 38:985-993.
21. Lupke M, Frahm J, Lantow M, Maercker C, Remondini D, Bersani F, Simkó M. 2006. Gene expression analysis of ELF-MF exposed human monocytes indicating the involvement of the alternative activation pathway. Biochim Biophys Acta 1763:402-412.
22. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, Radomski MW, Moncada S. 1994. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 91:6702-6706.
23. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
24. Newby AC. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85:1-31.
25. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. 2001. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276:29596-29602.
26. Oliver GW, Leferson JD, Stetler-Stevenson WG, Kleiner DE. 1997. Quantitative reverse zymography: Analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem 244:161-166.
27. Ozaki H, Miyashita Y, Watanabe H, Shirai K. 2005. Enhancement of MMP-9 activity in THP-1 cells by 7-ketocholesterol and its suppression by the HMG-CoA reductase inhibitor fluvastatin. J Atheroscler Thromb 12:308-314.
28. Patruno A, Amerio P, Pesce M, Vianale G, Di Luzio S, Tulli A, Franceschelli S, Grilli A, Muraro R, Reale M. 2010. Extremely low frequency electromagnetic fields modulate expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and cyclooxygenase-2 in the human keratinocyte cell line HaCaT: Potential therapeutic effects in wound healing. Br J Dermatol 162:258-266.
29. Pfeiffer S, Mayer B, Hemmens B. 1999. Nitric oxide: Chemical puzzles posed by a biological messenger Angew Chem Int Ed 38:1714-1731.
30. Pritchard KA, Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stemerman MB. 1995. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 77:510-518.
31. Radi R. 2004. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 101:4003-4008.
32. Reale M, De Lutiis MA, Patruno A, Speranza L, Felaco M, Grilli A, Macrì MA, Comani S, Conti P, Di Luzio S. 2006. Modulation of MCP-1 and iNOS by 50-Hz sinusoidal electromagnetic field. Nitric Oxide 15:50-57.
33. Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, Wink DA. 2007. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad Sci USA 104:16898-16903.
34. Rivera S, Ogier C, Jourquin J, Timsit S, Szklarczyk AW, Miller K, Gearing AJ, Kaczmarek L, Khrestchatisky M. 2002. Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 15:19-32.
35. Sehgal I, Thompson TC. 1999. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell 10:407-416.
36. Simkò M. 2007. Cell type specific redox status is responsible for diverse electromagnetic field effects. Curr Med Chem 14:1141-1152.
37. Simkó M, Droste S, Kriehuber R, Weiss DG. 2001. Stimulation of phagocytosis and free radical production in murine macrophages by 50Hz electromagnetic fields. Eur J Cell Biol 80:562-566.
38. Sun M, Zigman S. 1978. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem 90:81-89.
39. Tenforde TS. 1992. Biological interactions and potential health effects of extremely-low-frequency magnetic fields from power lines and other common sources. Annu Rev Public Health 13:173-196.
40. van Buul JD, Hordijk PL. 2004. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24:824-833.
41. Van Wart HE, Birkedal-Hansen H. 1990. The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87:5578-5582.
42. Vaz SM, Prado FM, Di Mascio P, Augusto O. 2009. Oxidation and nitration of ribonuclease and lysozyme by peroxynitrite and myeloperoxidase. Arch Biochem Biophys 484:127-133.
43. Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92:827-839.
44. Walpen S, Beck KF, Eberhardt W, Apel M, Chatterjee PK, Wray GM, Thiemermann C, Pfeilschifter J. 2000. Downregulation of SPARC expression is mediated by nitric oxide in rat mesangial cells and during endotoxemia in the rat. J Am Soc Nephrol 11:468-476.
45. Worley JR, Baugh MD, Hughes DA, Edwards DR, Hogan A, Sampson MJ, Gavrilovic J. 2003. Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. J Biol Chem 278:51340-51346.
46. Worthylake RA, Burridge K. 2001. Leukocyte transendothelial migration: Orchestrating the underlying molecular machinery. Curr Opin Cell Biol 13:569-577.
47. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1:611-617.
48. Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, Sowa P, Polaniak R, Birkner E, Latocha M, Pilc K, Suchanek R. 2005. Effect of extremely low frequency of electromagnetic fields on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes-an in vitro study. J Physiol Pharmacol 56:101-108.